Total Payments
$830.57
2024 Payments
$134.22
Companies
11
Transactions
26
Medicare Patients
8,561
Medicare Billing
$776,946
Payment Breakdown by Category
Food & Beverage$798.09 (96.1%)
Education$32.48 (3.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $798.09 | 24 | 96.1% |
| Education | $32.48 | 2 | 3.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| BioFire Diagnostics, LLC | $180.32 | 1 | $0 (2018) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $173.63 | 4 | $0 (2024) |
| JAZZ PHARMACEUTICALS INC. | $138.06 | 1 | $0 (2022) |
| GlaxoSmithKline, LLC. | $135.73 | 5 | $0 (2024) |
| Gilead Sciences, Inc. | $45.78 | 3 | $0 (2022) |
| United Therapeutics Corporation | $34.41 | 2 | $0 (2023) |
| Insmed, Inc. | $32.48 | 2 | $0 (2024) |
| Genentech USA, Inc. | $29.50 | 2 | $0 (2019) |
| Sunovion Pharmaceuticals Inc. | $25.84 | 4 | $0 (2017) |
| Inspire Medical Systems, Inc. | $18.11 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $134.22 | 5 | GlaxoSmithKline, LLC. ($78.03) |
| 2023 | $36.81 | 2 | GlaxoSmithKline, LLC. ($21.69) |
| 2022 | $204.62 | 5 | JAZZ PHARMACEUTICALS INC. ($138.06) |
| 2021 | $30.95 | 2 | Janssen Pharmaceuticals, Inc ($16.71) |
| 2019 | $170.36 | 4 | Boehringer Ingelheim Pharmaceuticals, Inc. ($116.98) |
| 2018 | $207.20 | 3 | BioFire Diagnostics, LLC ($180.32) |
| 2017 | $46.41 | 5 | Sunovion Pharmaceuticals Inc. ($25.84) |
All Payment Transactions
26 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/20/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $27.31 | General |
| Category: IMMUNOLOGY | ||||||
| 10/15/2024 | Insmed, Inc. | Arikayce (Drug) | Education | In-kind items and services | $16.24 | General |
| Category: Respiratory | ||||||
| 10/07/2024 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $50.72 | General |
| 05/14/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $18.11 | General |
| Category: NEUROLOGY | ||||||
| 02/23/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $21.84 | General |
| 12/04/2023 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $21.69 | General |
| Category: IMMUNOLOGY | ||||||
| 02/06/2023 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $15.12 | General |
| Category: PAH | ||||||
| 11/16/2022 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $138.06 | General |
| Category: NEUROLOGY | ||||||
| 06/15/2022 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $19.29 | General |
| Category: PAH | ||||||
| 04/27/2022 | Gilead Sciences, Inc. | Veklury (Drug) | Food and Beverage | In-kind items and services | $18.90 | General |
| Category: COVID-19 | ||||||
| 04/20/2022 | Insmed, Inc. | Arikayce (Drug) | Education | In-kind items and services | $16.24 | General |
| Category: Respiratory | ||||||
| 02/10/2022 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $12.13 | General |
| Category: IMMUNOLOGY | ||||||
| 08/04/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $16.71 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/21/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $14.24 | General |
| Category: RESPIRATORY | ||||||
| 12/09/2019 | Genentech USA, Inc. | Rituxan Hycela (Biological) | Food and Beverage | In-kind items and services | $12.75 | General |
| Category: BioOncology/Immunology | ||||||
| 10/14/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $116.98 | General |
| 05/16/2019 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $23.88 | General |
| Category: RESPIRATORY | ||||||
| 03/21/2019 | Genentech USA, Inc. | Esbriet (Biological) | Food and Beverage | In-kind items and services | $16.75 | General |
| Category: Immunology | ||||||
| 10/15/2018 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $10.79 | General |
| 05/22/2018 | BioFire Diagnostics, LLC | BioFire FilmArray (Device) | Food and Beverage | In-kind items and services | $180.32 | General |
| Category: Clinical Diagnostics | ||||||
| 04/10/2018 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $16.09 | General |
| 09/27/2017 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO (Drug), SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $20.57 | General |
| Category: RESPIRATORY | ||||||
| 09/18/2017 | Sunovion Pharmaceuticals Inc. | UTIBRON (Drug) | Food and Beverage | In-kind items and services | $7.11 | General |
| Category: RESPIRATORY | ||||||
| 08/07/2017 | Sunovion Pharmaceuticals Inc. | UTIBRON (Drug) | Food and Beverage | In-kind items and services | $6.97 | General |
| Category: RESPIRATORY | ||||||
| 04/24/2017 | Sunovion Pharmaceuticals Inc. | UTIBRON (Drug) | Food and Beverage | In-kind items and services | $8.33 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 25 | 2,205 | 2,453 | $707,195 | $176,217 |
| 2022 | 26 | 2,004 | 2,361 | $715,260 | $176,181 |
| 2021 | 27 | 2,007 | 2,351 | $834,627 | $208,346 |
| 2020 | 26 | 2,345 | 2,642 | $885,461 | $216,203 |
Total Patients
8,561
Total Services
9,807
Medicare Billing
$776,946
Procedure Codes
120
All Medicare Procedures & Services
120 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Office | 2023 | 94 | 106 | $212,000 | $50,398 | 23.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 236 | 308 | $93,940 | $27,086 | 28.8% |
| 95810 | Sleep study in sleep lab (6 years or older) | Office | 2023 | 54 | 54 | $97,200 | $24,744 | 25.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 165 | 175 | $39,385 | $10,586 | 26.9% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 24 | 57 | $35,910 | $8,983 | 25.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 50 | 50 | $29,000 | $7,623 | 26.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 47 | 49 | $19,845 | $5,881 | 29.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 44 | 44 | $20,240 | $4,894 | 24.2% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 99 | 113 | $17,515 | $4,324 | 24.7% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 154 | 169 | $29,575 | $4,218 | 14.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 33 | 71 | $14,555 | $4,094 | 28.1% |
| 94726 | Test to determine lung volumes using sensors | Office | 2023 | 77 | 81 | $12,150 | $2,882 | 23.7% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 14 | 26 | $7,670 | $2,281 | 29.7% |
| 94726 | Test to determine lung volumes using sensors | Facility | 2023 | 264 | 265 | $10,600 | $2,273 | 21.4% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 18 | 18 | $10,260 | $2,257 | 22.0% |
| 31624 | Irrigation and suction of lung airways to obtain cells using an endoscope | Facility | 2023 | 20 | 20 | $12,900 | $1,917 | 14.9% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 24 | 24 | $2,400 | $1,819 | 75.8% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2023 | 268 | 269 | $8,070 | $1,710 | 21.2% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2023 | 220 | 221 | $8,840 | $1,579 | 17.9% |
| 99292 | Critical care, each additional 30 minutes | Facility | 2023 | 12 | 17 | $5,355 | $1,388 | 25.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 12 | 12 | $3,720 | $856.06 | 23.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 27 | 27 | $1,080 | $802.17 | 74.3% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 38 | 40 | $4,200 | $766.65 | 18.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 15 | 15 | $1,875 | $637.39 | 34.0% |
| 94762 | Test to measure oxygen level in blood using ear or finger device continuously overnight | Office | 2023 | 26 | 34 | $2,550 | $605.12 | 23.7% |
About Dr. David Panossian, MD
Dr. David Panossian, MD is a Critical Care Medicine healthcare provider based in Klamath Falls, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1366504532.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Panossian, MD has received a total of $830.57 in payments from pharmaceutical and medical device companies, with $134.22 received in 2024. These payments were reported across 26 transactions from 11 companies. The most common payment nature is "Food and Beverage" ($798.09).
As a Medicare-enrolled provider, Panossian has provided services to 8,561 Medicare beneficiaries, totaling 9,807 services with total Medicare billing of $776,946. Data is available for 4 years (2020–2023), covering 120 distinct procedure/service records.
Ad
Practice Information
- Specialty Critical Care Medicine
- Other Specialties Pulmonary Disease, Sleep Medicine
- Location Klamath Falls, OR
- Active Since 12/14/2006
- Last Updated 06/24/2025
- Taxonomy Code 207RC0200X
- Entity Type Individual
- NPI Number 1366504532
Products in Payments
- BioFire FilmArray (Device) $180.32
- XYWAV (Drug) $138.06
- NUCALA (Biological) $85.01
- TYVASO (Drug) $34.41
- Arikayce (Drug) $32.48
- UTIBRON (Drug) $22.41
- STIOLTO (Drug) $20.57
- Veklury (Drug) $18.90
- INSPIRE (Device) $18.11
- Esbriet (Biological) $16.75
- XARELTO (Drug) $16.71
- OFEV (Drug) $14.24
- Rituxan Hycela (Biological) $12.75
- BROVANA (Drug) $3.43
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.